Predict falls by assessing balance
- Trial ID
- NCT07148700
- Official Title
- Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment
- Goal
- Predict falls by assessing balance
- Status
- RECRUITING
- Sponsor
- Bezmialem Vakif University
- Study Type
- OBSERVATIONAL
- Enrollment
- 40 participants
- Conditions
- PARKINSON DISEASE (Disorder), Parkinson, Parkinson s Disease, Parkinson Disease, Parkinson Disease (PD)
Plain-Language Summary
The goal is to find which way of measuring balance and falls best predicts future fall risk in people with mild to moderate Parkinson's (Hoehn and Yahr stages 1 to 3). To do that, researchers will compare objective device-based measures like gait and sway recordings, self-reported tools such as fall history and balance-confidence questionnaires, and practical functional balance tests that watch you perform standing and walking tasks, with measurements taken while participants are on their usual stable dopaminergic medications. They're enrolling people 40 to 80 years old with Parkinson's who are on stable dopaminergic treatment, have a Mini-Mental State Exam score above 24, and no other neurological disorders. People with major vision, hearing, heart or lung problems, recent rehabilitation, severe communication issues, or clinical instability in the past month are not eligible.
Locations
- Bezmialem Vakif University, Istanbul, Eyup, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to find which way of measuring balance and falls best predicts future fall risk in people with mild to moderate Parkinson's (Hoehn and Yahr stages 1 to 3). To do that, researchers will compare objective device-based measures like gait and sway recordings, self-reported tools such as fall history and balance-confidence questionnaires, and practical functional balance tests that watch you perform standing and walking tasks, with measurements taken while participants are on their usual stable dopaminergic medications. They're enrolling people 40 to 80 years old with Parkinson's who are on stable dopaminergic treatment, have a Mini-Mental State Exam score above 24, and no other neurological disorders. People with major vision, hearing, heart or lung problems, recent rehabilitation, severe communication issues, or clinical instability in the past month are not eligible.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 4 months.